Cargando…
Autoimmune limbic encephalitis combined with leptomeningeal metastases of non-small cell lung cancer: treatment response to osimertinib, immunoglobulin, rituximab, and tocilizumab
When a patient with encephalopathy has an organic brain lesion, his symptom is easily and often mistakenly attributed to that brain lesion. However, a combination of different conditions is also possible. We present a case of autoimmune limbic encephalitis combined with leptomeningeal carcinomatosis...
Autores principales: | Lee, Seolah, Ahn, Seon-Jae, Lee, Han Sang, Chu, Kon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Encephalitis and Neuroinflammation Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295819/ https://www.ncbi.nlm.nih.gov/pubmed/37469717 http://dx.doi.org/10.47936/encephalitis.2022.00122 |
Ejemplares similares
-
The safety and efficacy of intravenous immunoglobulin in autoimmune encephalitis
por: Lee, Soon‐Tae, et al.
Publicado: (2022) -
Efficacy of Tocilizumab in Limbic Encephalitis with Anti-CASPR2 Antibodies
por: Benucci, Maurizio, et al.
Publicado: (2020) -
Osimertinib in combination with bevacizumab in EGFR-Mutated NSCLC with leptomeningeal metastases
por: Jiang, Tao, et al.
Publicado: (2020) -
Anti-LGI1 Limbic Encephalitis Presented with Atypical Manifestations
por: Lee, Jung-Ju, et al.
Publicado: (2013) -
Invasion of small cell lung cancer into the limbic system from leptomeningeal metastases
por: Higo, Hisao, et al.
Publicado: (2021)